Table 1. Overview of the TB epidemic in Belarus, South Africa, and Vietnam [18].
| Indicator | Belarus | South Africa | Vietnam |
|---|---|---|---|
| Total population (2017) | 9.5 million | 57 million | 96 million |
| TB prevalence (all forms) | 32.1 per 100,000 | 398.6 per 100,000 | 110.1 per 100,000 |
| TB incidence (new and relapse cases) | 29.3 per 100,000 | 386.3 per 100,000 | 107.0 per 100,000 |
| HIV prevalence among TB | 2.9 per 100,000 | 340 per 100,000 | 4.7 per 100,000 |
| Incidence of MDR/RR-TB | 26 per 100,000 | 25 per 100,000 | 7.4 per 100,000 |
| Percent of new cases with MDR/RR-TB | 38% (36–41) | 3.4% (2.5–4.3) | 4.1% (2.8–5.7) |
| Percent of retreated cases with MDR/RR-TB | 67% (63–70) | 7.1% (4.8–9.5) | 17% (17–18) |
| TB treatment coverage | 80% | 68% | 83% |
| MDR/RR-TB treatment success rate (2015) | 64% (cohort size: 1,400) | 55% (cohort size: 9,750) | 74% (cohort size: 2,045) |
| XDR-TB treatment success rate (2015) | 53% (cohort size: 508) | 48% (cohort size: 427) | Not reported |
Abbreviations: MDR/RR-TB, multidrug-resistant/rifampicin-resistant TB; TB, tuberculosis; XDR-TB, extensively drug-resistant TB